Loading...
Loading...
Oliver "An Englishman in New York" Barnes is on a bit of a hot streak.
So pharmaceutical giant Merck is no longer in talks to buy Revolution Medicines for over $20 billion.
The venerable Financial Times is on a bit of a hot streak.
Hacks at the Financial Times have dug out another cracking biotechnology takeover scoop.
It's good to see hacks at the venerable Financial Times follow up on little old Betaville's UNCOOKED Alert about US-listed biotechnology company MoonLake Immunotherapeutics.
Rivals at Reuters have finally decided to follow up little old Betaville's UNCOOKED Alerts about the takeover rumours surrounding US-listed biopharmaceutical company SpringWorks Therapeutics.
I see little old Betaville's former boss Mark "The Kleinmanator" Kleinman of Sky News has decided to follow up on this website's UNCOOKED Alert about Incyte Corporation that was published a couple of weeks ago.